We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Drug Target for Acute Myeloid Leukaemia

News   Nov 28, 2017 | Original story from Wellcome Trust Sanger Institute

 
New Drug Target for Acute Myeloid Leukaemia

Acute myeloid leukamia (AML) cells. Genomic research has found that AML cannot survive without the METTL3 gene, making it a strong therapeutic target. Image credit: The Armed Forces Institute of Pathology (AFIP)

 
 
 

RELATED ARTICLES

Circular RNAs Have Important Role in Innate Immunity

News

Scientists discovered that most examined circRNAs tend to form 16-26 bp intramolecularly imperfect RNA duplexes. In addition, circRNAs preferentially bind to dsRNA-activated protein kinase (PKR) which is related to innate immunity and act as PKR inhibitors.

READ MORE

Mission Bio Scales Executive Leadership Team With Three New Hires

News

Darrin Crisitello, Nigel Beard, and Marcel Roche join Mission Bio, bringing extensive experience in scaling advanced genomics technologies and markets to over $1 billion in revenue.

READ MORE

Cell Transplant Helps Restore Muscle Mass Lost After Immobility

News

By injecting cells that support blood vessel growth into muscles depleted by inactivity, researchers say they are able to help restore muscle mass lost as a result of immobility.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE